Eugene Zhukovsky joins Affimed as CSO
This article was originally published in Scrip
Affimed Therapeutics, a therapeutic antibody company, has appointed Dr Eugene Zhukovsky chief scientific officer, effective 1 January 2012. Dr Zhukovsky has 20 years' experience in biotherapeutics research and development. He was most recently a senior research fellow in the biotherapeutics department at Boehringer Ingelheim.